68Ga-pentixafor PET/CT Is a Supplementary Method for Primary Aldosteronism Subtyping Compared with Adrenal Vein Sampling
2024 · Molecular Imaging and Biology · 8 citations
https://doi.org/10.1007/s11307-024-01976-0
D
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
64
Papers
519
Citations
10
h-index
10
i10-index
Difei Lu is an academic researcher from Chinese Academy of Medical Sciences & Peking Union Medical College. The author has contributed to research in topics: Diabetes Treatment and Management & Cancer Immunotherapy and Biomarkers & Computer Graphics and Visualization Techniques. The author has an h-index of 10, co-authored 55 publications.
ORCID: 0000-0003-3953-8900Papers by this author
worksThe COVID-19 vaccination hesitancy among Chinese individuals with diabetes and the impact on glycemic control of vaccination: a questionnaire study
2022 · BMC Endocrine Disorders · 7 citations
https://doi.org/10.1186/s12902-022-01201-5
Efficacy of Dorzagliatin and Related Factors in a Real‐World Cohort of Type 2 Diabetes
2025 · Journal of Diabetes Research · 0 citations
https://doi.org/10.1155/jdr/9950032
Flavin‐Containing Monooxygenase 3 Genetic Variants and Possible Susceptibility to Coronary Heart Disease Among Han Chinese With Type 2 Diabetes
2025 · International Journal of Endocrinology · 0 citations
https://doi.org/10.1155/ije/1020054
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat